MarketPeel
Insider Trading Intelligence
Pricing
…
BS

Brent L. Saunders

BLCO
CEO AND CHAIRMAN OF THE BOARD · BAUSCH & LOMB CORP · CIK 0001268854
FILING MIX · LIFETIME69%/31%
BUYS
40
SELLS
18
TOTAL VALUE
$7.87M
COMPANIES
5
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
7,128,042
AVG SELL PX
$16.30
TRADE KIND
SHOWING 58 / 58
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brent L. Saunders, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+71.43%+4.18%+0.90%+3.29%+2.31%—
14d7+57.14%+4.86%+1.90%+2.96%-0.26%—
30d7+57.14%+0.45%+0.70%-0.25%+2.35%—
60d7+42.86%+3.83%+4.63%-0.80%+11.91%—
90d7+57.14%-2.97%+6.74%-8.04%+3.98%—
180d7(1 pending)+66.67%-10.83%+8.79%-19.62%-10.29%—
1y7(1 pending)+50.00%-9.25%+17.64%-26.90%-28.55%—
2y7(3 pending)+50.00%+19.87%+36.52%-16.65%-67.37%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BLCO · 974,158 shares · as of Aug 5, 2026
0314,009628,019942,0281,256,03720252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 40 buys / 18 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BLCO
BAUSCH & LOMB CORP
SALE
Chairman of the Board and CEO
4,231$16.76$70.9K974,158Aug 5, 2026Aug 7, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
281,879——1,256,037Aug 5, 2026Aug 7, 2026 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Jun 24, 2026Jun 26, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
SALE
Chairman of the Board and CEO
2,886$15.92$45.9K978,389May 22, 2026May 26, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
14,700——981,275Mar 6, 2026Mar 9, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASE
CEO and Chairman of the Board
14,700$17.14$252.0K966,575Mar 6, 2026Mar 9, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
SALE
CEO and Chairman of the Board
24,649$18.30$451.1K951,875Feb 27, 2026Mar 2, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
SALE
CEO and Chairman of the Board
22,059$18.49$407.9K976,524Feb 26, 2026Mar 2, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
327,102——998,583Feb 25, 2026Feb 27, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
SALE
CEO and Chairman of the Board
65,444$17.99$1.18M671,481Feb 23, 2026Feb 25, 2026 ↗View →
BLCO
BAUSCH & LOMB CORP
SALE
CEO and Chairman of the Board
4,231$14.44$61.1K736,925Aug 5, 2025Aug 7, 2025 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
150,000——900,000Jul 21, 2025Jul 23, 2025 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
30,000——30,000Jun 25, 2025Jun 27, 2025 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
73,051——5,994,820Jun 16, 2025Jun 18, 2025 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASE
CEO and Chairman of the Board
22,000$11.28$248.1K719,156May 22, 2025May 27, 2025 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
22,000——741,156May 22, 2025May 27, 2025 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
SALE
120,000——470,950May 20, 2025May 22, 2025 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
SALE
120,000$14.25$1.71M0May 20, 2025May 22, 2025 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASE
120,000$1.01$121.2K120,000May 20, 2025May 22, 2025 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
168,168——697,156Feb 26, 2025Feb 28, 2025 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
600,858——600,858Feb 26, 2025Feb 28, 2025 ↗View →
BLCO
BAUSCH & LOMB CORP
SALE
CEO and Chairman of the Board
73,782$17.83$1.32M553,637Dec 23, 2024Dec 24, 2024 ↗View →
BLCO
BAUSCH & LOMB CORP
SALE
CEO and Chairman of the Board
24,649$17.83$439.5K528,988Dec 23, 2024Dec 24, 2024 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASE
40,450$1.08$43.7K5,921,769Aug 12, 2024Aug 13, 2024 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
32,250——627,419Aug 5, 2024Aug 7, 2024 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASE
CEO and Chairman of the Board
32,250$15.66$505.1K595,169Aug 5, 2024Aug 7, 2024 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
78,534——5,881,319Jul 8, 2024Jul 10, 2024 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 20, 2024Jun 24, 2024 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
569,105——569,105Feb 28, 2024Mar 1, 2024 ↗View →
BLCO
BAUSCH & LOMB CORP
PURCHASEGRANT
Stock grant
187,919——562,919Feb 28, 2024Mar 1, 2024 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASE
59,380$6.10$362.4K5,827,453Aug 16, 2023Aug 17, 2023 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,000——40,000Jun 27, 2023Jun 28, 2023 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
16,357——5,768,073Jun 14, 2023Jun 16, 2023 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
SALE
13,548$12.90$174.8K5,802,785Feb 3, 2023Jul 10, 2024 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
SALE
2,167$9.10$19.7K5,816,333Dec 30, 2022Jul 10, 2024 ↗View →
CSCO
CISCO SYSTEMS, INC.
PURCHASEGRANT
Stock grant
5,001——24,143Dec 8, 2022Dec 12, 2022 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
153,647——153,647Nov 8, 2022Nov 10, 2022 ↗View →
SPRY
ARS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
590,950——590,950Nov 8, 2022Nov 10, 2022 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
SALE
2,166$11.79$25.5K5,818,500Sep 30, 2022Jul 10, 2024 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
SALE
3,076$12.86$39.6K5,820,666Jun 30, 2022Jul 10, 2024 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
104,921——104,921Jun 22, 2022Jun 24, 2022 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
SALE
3,711$16.88$62.6K5,823,742Mar 31, 2022Jul 10, 2024 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
35,581——5,593,266Feb 4, 2022Feb 8, 2022 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
158,450——5,751,716Feb 4, 2022Feb 8, 2022 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
SALE
6,812$12.24$83.4K5,557,685Jan 27, 2022Jan 31, 2022 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
17,600$14.48$254.9K17,600Dec 29, 2021Jan 3, 2022 ↗View →
CSCO
CISCO SYSTEMS, INC.
PURCHASEGRANT
Stock grant
4,180——32,503Dec 13, 2021Dec 15, 2021 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
60,000——60,000Sep 10, 2021Sep 14, 2021 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
30,963——5,564,497Sep 10, 2021Sep 14, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
38,895——38,895Jun 17, 2021Jun 22, 2021 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
SALE
11,500,000——0May 14, 2021May 18, 2021 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
SALE
9,333,333——0May 14, 2021May 18, 2021 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
1,860,000——1,860,000May 6, 2021May 10, 2021 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASE
Executive Chairman
11,500,000——11,500,000May 4, 2021May 10, 2021 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASE
Executive Chairman
11,500,000——0May 4, 2021May 10, 2021 ↗View →
CSCO
CISCO SYSTEMS, INC.
PURCHASEGRANT
Stock grant
5,189——27,543Dec 10, 2020Dec 14, 2020 ↗View →
SKIN
SKINHEALTH SYSTEMS INC.
PURCHASEGRANT
Stock grant
9,333,333——9,333,333Oct 2, 2020May 18, 2021 ↗View →
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
101,223——101,223Jun 23, 2020Jun 24, 2020 ↗View →
Other insiders · BLCO
Loading peer insiders…
About this filer
CIK 0001268854
ROLE
CEO and Chairman of the Board
PRIMARY
BLCO
COMPANIES
5
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001268854DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback